FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.
about
FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.
@ast
FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.
@en
type
label
FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.
@ast
FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.
@en
prefLabel
FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.
@ast
FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.
@en
P2093
P2860
P1476
FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma.
@en
P2093
Alexey V Danilov
Frederick Lansigan
Larry J Dumont
Norman B Levy
Olga V Danilova
Prabhjot Kaur
William B Kinlaw
P2860
P356
10.1007/S12308-012-0166-4
P577
2013-03-01T00:00:00Z